5 issues to know earlier than the inventory market opens Tuesday | USAEMALL.com

Good morning. Fresh off his feature in Salesforce’s Super Bowl ad, MrBeast is getting into banking. The YouTuber, whose real name is Jimmy Donaldson, said Monday that his company Beast Industries acquired the financial services app Step.

Stock futures are little changed this morning after all three major averages posted gains to start the week.

Here are five key things investors need to know to start the trading day:

Tech stocks lifted the overall market yesterday, helping the S&P 500 notch its second day in a row of gains. The Dow Jones Industrial Average also reached new intraday and closing records.

Here’s what to know:

• Shares of Oracle rose 9% in the session. Microsoft and Broadcom both added more than 3%, while Nvidia and Meta closed more than 2% higher.
• The gains in the sector follow last week’s tech stock rout, which saw Big Tech lose more than $1 trillion from their market caps.
• Shares of Spotify and CVS Health are moving before the bell this morning after reporting earnings. Spotify is up more than 10% after reporting a jump in users, while CVS is more than 2% lower despite a top- and bottom-line beat.
• On the economic data front, investors will get the latest retail sales numbers this morning, which are expected to show a 0.5% gain on the month.
• All eyes are still on tomorrow’s big jobs report. The January release was originally scheduled for last week but delayed by the partial government shutdown.
• Follow live market updates here.

Shares of Coca-Cola are lower this morning after the beverage company reported mixed results for its fourth quarter. Adjusted earnings per share were better than expected for the period, but adjusted revenue came in at $11.82 billion — short of the $12.03 billion Wall Street was expecting.

Coca-Cola said it projects 4% to 5% organic revenue growth in 2026. The company, like rival Pepsi, has seen weakening demand for its offerings as shoppers try to save more at the grocery store.

Alphabet is preparing to spend big on artificial intelligence. At the same time, the Google parent is acknowledging the risks.

In its annual financial report last week, the company warned — for the first time — that greater use of generative AI by consumers could change its core advertising business. As CNBC’s Jennifer Elias reports, Alphabet also noted risks tied to its sizable AI infrastructure investments.

The tech giant plans to raise $20 billion from a U.S. dollar bond sale to fund its AI build-out, according to people familiar with the matter. Alphabet said in its earnings report last week that its capital expenditures in 2026 could more than double those of 2025.

Target is shifting its resources in hopes of fixing its in-store experience problem.

In an internal memo obtained by CNBC, the retailer said Monday that it is increasing store staffing but cutting around 500 jobs at distribution centers and regional offices. The move “fuels our ability to put significantly more payroll in our stores — primarily in additional labor and hours where needed most, but also in new guest experience training for every team member at every store,” the email said.

Improving shoppers’ in-store experience is a priority for newly minted Target CEO Michael Fiddelke, who took the helm at the beginning of this month. Target and Fiddelke are hoping to win back customers driven away by complaints of messy shelves and long check-out lines.

Novo Nordisk is facing regulatory scrutiny from the Food and Drug Administration, which said in a letter dated last week that the drugmaker’s TV ad for its new Wegovy pill includes “false or misleading” claims.

The FDA said the ad — which Novo clarified is not the company’s star-studded Super Bowl spot — misbrands the oral weight-loss drug, a violation of federal law. A spokesperson for the company said it is “in the process of responding to the FDA to address their concerns.”

U.S.-listed shares of the Danish drugmaker ended yesterday’s trading session more than 3% higher. Meanwhile, shares of Hims & Hers, which Novo said Monday it would sue over its copycat obesity pill, dropped 16%.

It may be America’s oldest bank, but BNY is going all in on new technology, including “digital employees.” Here’s why the bank is spending billions on AI, and why it says that won’t come at the expense of human workers:

— CNBC’s Dylan Butts, Sean Conlon, Sarah Min, Annika Kim Constantino, Amelia Lucas, Jennifer Elias, Melissa Repko, Leslie Picker and Ritika Shah contributed to this report. Melodie Warner edited this edition.